Bridging epidemiological data gaps to inform prospective commercial appeal

Understanding the probable success of various launch indications.

The brief

Our client sought to understand both the prospective commercial appeal and probable success of various launch indications. Our evaluation encompassed a comprehensive epidemiological assessment, as well as clinical, competitive and price landscaping.  

The challenge                                                        

The aim of this project was to empower our client with the necessary data and insights to shape their future launch strategy and market positioning. To address data gaps, we conducted a thorough epidemiological analysis of the relevant disease landscape in our client’s markets of interest. Our findings were reinforced by an in-depth report on the clinical, competitive and price landscapes.  

The solution

We delivered a comprehensive solution to our client, housed within bespoke, thoughtfully designed intelligence boards.  

  • A systematic literature review allowed us to extract and analyze epidemiology data that we enriched with models of disease prevalence with flexible filtering for variables of interest.  
  • Findings were contextualized against a background of the evolving competitor landscape. An intelligence board detailing the pricing landscape in markets relevant to our client was also created.
  • We also conducted a digital listening exercise so that we could assess the sentiment surrounding competitor products, providing our client with valuable insight into the market opportunity.  

Value to the client

A rapid and robust epidemiological analysis, coupled with VISFO’s strategic recommendations, allowed our client to fully understand the early commercial attractiveness of their product and refine their future launch strategy.  

 

Want to work with us?

We would love to hear from you!

Get in touch.